Dabur Oncology

Rediff.com » News » Dabur Oncology

News for Dabur Oncology

Business

Alembic buys Dabur's non-oncology business

Dabur Pharma has sold its entire non-oncology business to Alembic for approximately Rs 167 crore (Rs 1.67 billion). With the deal, Dabur becomes the country's first and only speciality drug company......

Dabur Pharma eyes US, Europe

Dabur Pharma, a leading player in the domestic oncology segment, is busy finalising its marketing strategies for EU, the US and Australia. The company is expecting five regulatory approvals in......

What Dabur promoters plan to do

In a move to focus on its core FMCG strength, the Burman family, promoters of Dabur India, last week announced their exit from the pharma business. The Burmans sold Dabur Pharma - the oncology......

Dabur on fast track to good health

After hiving off its non-oncology drugs business last year, the Dabur group recently divested its entire stake in Dabur Pharma to Fresenius Kabi, a 100 per cent subsidiary of the Germany-based......

Why Fortis Healthcare has a bevy of suitors

With over 45 healthcare facilities and over 300 vibrant diagnostic centres, Fortis is India’s second-largest hospital chain -- next only to Apollo, which has 64 hospitals with 10,000 beds.......

Dabur Oncology

News for Dabur Oncology

Alembic buys Dabur's non-oncology business

Dabur Pharma eyes US, Europe

What Dabur promoters plan to do

Dabur on fast track to good health

Why Fortis Healthcare has a bevy of suitors

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS